Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Daily Brief: Trump arrives in London, NICE says no to Darzalex, Pfizer backs down on prices

The latest from pharma, biotech and healthcare

Roche Basel Switzerland

Roche keeps Venclexta train rolling with new leukaemia filing

The drug could treat AML patients who are ineligible for chemotherapy

- PMLiVE

Pfizer builds gap between pharma and consumer health units

Its consumer health division will become a standalone unit after lack of buyer interest

- PMLiVE

The Pharma UK Twitter Ranking 2018 [RESEARCH]

The second edition in our Pharma Social Media Series, the UK Twitter Ranking.

An agency called Owen

- PMLiVE

Some pharma companies not prepared for Brexit, warns EMA

Regulator concerned about medicines shortages after March 2019

- PMLiVE

VC raises new €270m fund for European biotechs

The money will mostly go to companies working on novel therapies

- PMLiVE

Christina Coughlin to leave Immunocore for Tmunity

UPenn pioneers building their own biotech company

AstraZeneca AZ

AZ makes gene therapy move with 4DMT alliance

The new partnership will focus on creating an AAV for lung disease

The rise of vertical integration in the US payer landscape

Is it a solution to addressing the challenges of the value-based marketplace?

- PMLiVE

Rebecca Grant to lead newly-formed Burson Cohn & Wolfe UK

Experienced leader takes on merged comms group

- PMLiVE

Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome ready to leap into future

A round-up from pharma, biotech and healthcare

- PMLiVE

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links